Introduction | 1 | PPT | |

Biotechnology in 21st Century | 2 | PPT | |

Roots of Biotechonology | 3 | PPT | |

Roots of Biotechonology_2 | 4 | PPT | |

Discovery of DNA | 5 | PPT | |

Dawn of Biotechnology | 6 | PPT | |

Commercialising Biotechnology | 7 | PPT | |

Biotechnology Giants | 8 | PPT | |

PCR & Biotechnology | 9 | PPT | |

Human Genome Project | 10 | PPT | |

Human Genome Project | 11 | PPT | |

Emerging Fields | 12 | PPT | |

Pharmacogenomics | 13 | PPT | |

Structure of DNA | 14 | PPT | |

Replication | 15 | PPT | |

Replication_2 | 16 | PPT | |

Transcription 1 | 17 | PPT | |

Transcription 2 | 18 | PPT | |

Transcription 3 | 19 | PPT | |

Code of Codons | 20 | PPT | |

Translation 1 | 21 | PPT | |

Translation 2 | 22 | PPT | |

Translation 3 | 23 | PPT | |

Expanding the genetic code | 24 | PPT | |

Amino Acids | 25 | PPT | |

Peptide Bond | 26 | PPT | |

Foreces Defining Protein Structure | 27 | PPT | |

Foreces Defining Protein Structure_2 | 28 | PPT | |

Secondary Structure | 29 | PPT | |

alpha-helix | 30 | PPT | |

beeta-sheets | 31 | PPT | |

Super Secondary & Tertiary | 32 | PPT | |

Super Secondary & Tertiary_2 | 33 | PPT | |

Engineering the three domains | 34 | PPT | |

Engineering the three domains_2 | 35 | PPT | |

Learning from extremophiles | 36 | PPT | |

Learning from extremophiles_2 | 37 | PPT | |

Engineering the Prokaryotes | 38 | PPT | |

Restriction Endonuclease_1 | 39 | PPT | |

Restriction Endonuclease_2 | 40 | PPT | |

DNA Ligase | 41 | PPT | |

Vectors in Prokayotes | 42 | PPT | |

Plasmid Classification | 43 | PPT | |

Bacterial Plasmids | 44 | PPT | |

Development of Plasmids | 45 | PPT | |

Insertional Inactivation | 46 | PPT | |

Expression vectors | 47 | PPT | |

Life cycle of Bacteriophage | 48 | PPT | |

Vectors based on the lambda _1 | 49 | PPT | |

Vectors based on the lambda _2 | 50 | PPT | |

Genome of M13 | 51 | PPT | |

Vectors based on M13 | 52 | PPT | |

Cosmids | 53 | PPT | |

Making genomic libraries in E.coli | 54 | PPT | |

Do Bacteria Age | 55 | PPT | |

Bacterial Growth Curve | 56 | PPT | |

Measuring Bacterial Growth | 57 | PPT | |

High Copy number & Expression Strategies_1 | 58 | PPT | |

High Copy number & Expression Strategies_2 | 59 | PPT | |

Protein Secretion Pathway | 60 | PPT | |

Type 1 Protein Secretory Pathway | 61 | PPT | |

Type 2 Protein Secretory Pathway | 62 | PPT | |

Type 3 Protein Secretory Pathway | 63 | PPT | |

Type 3 Protein Secretory Pathway_2 | 64 | PPT | |

Type 4 Protein Secretory Pathway | 65 | PPT | |

Type 5& 6 Protein Secretory Pathway | 66 | PPT | |

Gram Positive Bacteria | 67 | PPT | |

Secretions & Biotechnology | 68 | PPT | |

Benefits to clone in Eukaryotes | 69 | PPT | |

Post translational modification of Proteins | 70 | PPT | |

Post translational modification of Proteins_2 | 71 | PPT | |

Types of Eukaryotic Expression System | 72 | PPT | |

Saccharomyces cerevisae | 73 | PPT | |

Transofrmation in Yeast | 74 | PPT | |

Yeast Vector 1 | 75 | PPT | |

Yeast Vector 2 | 76 | PPT | |

Yeast Vector 3 | 77 | PPT | |

Markers in Yeast | 78 | PPT | |

Promoters in Yeast | 79 | PPT | |

Pichia pastoris | 80 | PPT | |

Inclusion Bodies | 81 | PPT | |

Baculovirus-Insect Expression System | 82 | PPT | |

Baculovirus-Insect Expression System_2 | 83 | PPT | |

Biomimetics | 84 | PPT | |

Biomimetics_2 | 85 | PPT | |

Mammalian Cell Expression | 86 | PPT | |

Vectors for Mammalian Cell Expression | 87 | PPT | |

Vectors for Mammalian Cell Expression_2 | 88 | PPT | |

Enhancing the Productivity | 89 | PPT | |

Enhancing the Productivity_2 | 90 | PPT | |

Genome Editing Technologies | 91 | PPT | |

CRISPR CAS9 | 92 | PPT | |

CRISPR CAS9_2 | 93 | PPT | |

Pharmaceutical Biotechnology | 94 | PPT | |

Pharmaceutical Biotechnology Market | 95 | PPT | |

Hormones | 96 | PPT | |

Receptors and Drugable Proteins | 97 | PPT | |

Insuline the Hormone | 98 | PPT | |

Diabetes Mellitus | 99 | PPT | |

Insuline Receptor | 100 | PPT | |

Type 2 Diabetes | 101 | PPT | |

Insuline Molecule | 102 | PPT | |

Drawbacks of Animal Insuline | 103 | PPT | |

Genetical Engineered Insuline Production | 104 | PPT | |

Genetical Engineered Insuline Production_2 | 105 | PPT | |

Insuline Analogs | 106 | PPT | |

Insuline Analogs_2 | 107 | PPT | |

Glucagon | 108 | PPT | |

Human Growth Hormone | 109 | PPT | |

Human Growth Hormone the Molecule | 110 | PPT | |

Therapeutic use of Growth Hormone | 111 | PPT | |

Fertility Hormones | 112 | PPT | |

Male Reproductive System | 113 | PPT | |

Female Reproductive System | 114 | PPT | |

Female Reproductive System_2 | 115 | PPT | |

Follicle Stimulating Hormone | 116 | PPT | |

Applications of Gonadotrophins | 117 | PPT | |

Vaccine a Historic Prospective | 118 | PPT | |

Vaccine a Historic Prospective_2 | 119 | PPT | |

Traditional Vaccine Preparation | 120 | PPT | |

Traditional Vaccine Preparation_2 | 121 | PPT | |

Recombinant Vaccines | 122 | PPT | |

Recombinant Vaccines_2 | 123 | PPT | |

Recombinant Vaccines_3 | 124 | PPT | |

Peptide Vaccines | 125 | PPT | |

Medical Implants | 126 | PPT | |

Biosensors | 127 | PPT | |

Drug Development Process | 128 | PPT | |

Points of Care Diagnostics | 129 | PPT | |

Points of Care Diagnostics_2 | 130 | PPT | |

Points of Care Diagnostics_3 | 131 | PPT | |

Theranostics and Pay for Performance | 132 | PPT | |

Low Cost Diagnostics | 133 | PPT | |

Lateral Flow Immunoassay | 134 | PPT | |